• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心肌病的流行病学。一项对5252例尸检的前瞻性研究。心肌疾病研究组。

Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group.

作者信息

Rakar S, Sinagra G, Di Lenarda A, Poletti A, Bussani R, Silvestri F, Camerini F

机构信息

Cardiology Department, Ospedale Maggiore and University, Trieste, Italy.

出版信息

Eur Heart J. 1997 Jan;18(1):117-23. doi: 10.1093/oxfordjournals.eurheartj.a015092.

DOI:10.1093/oxfordjournals.eurheartj.a015092
PMID:9049523
Abstract

UNLABELLED

Dilated cardiomyopathy is a heart muscle disease of unknown aetiology, characterized by left ventricular dilatation and impaired systolic function. Data on the incidence and prevalence of the disease is ambiguous, due to geographic variations, patient selection and the diagnostic criteria adopted.

METHODS

All the post-mortem and clinical cases observed in a consecutive series of 5252 patients resident in Trieste during the period November 1987-November 1989 were studied.

RESULTS

Incidence of the disease discovered at autopsy was estimated at 4.5/100,000/year (24 cases), while clinical incidence in the same period was 2.45/100,000/year (13 cases). This is a total incidence of 6.95/100,000 new cases a year. A possible family history of heart muscle disease was found in three patients (12.5%). In 15 patients (62.5%) deaths were due to cardiological complications. Endocardial thickening (P = 0.03), fatty infiltration (P = 0.01) and arterial involvement (P = 0.04) were found more frequently in older patients (> 65 years).

CONCLUSIONS

The study confirms that dilated cardiomyopathy in Europe has a higher incidence than previously suggested and emphasizes the need for greater diagnostic sensitivity, particularly since pharmacological treatment is now so effective.

摘要

未标注

扩张型心肌病是一种病因不明的心肌疾病,其特征为左心室扩张和收缩功能受损。由于地域差异、患者选择和所采用的诊断标准,关于该疾病发病率和患病率的数据并不明确。

方法

对1987年11月至1989年11月期间居住在的里雅斯特的连续5252例患者中观察到的所有尸检和临床病例进行研究。

结果

尸检发现该疾病的发病率估计为4.5/100,000/年(24例),而同期临床发病率为2.45/100,000/年(13例)。这意味着每年新发病例的总发病率为6.95/100,000。在3例患者(12.5%)中发现可能有心肌病家族史。15例患者(62.5%)死于心脏并发症。老年患者(>65岁)的心内膜增厚(P = 0.03)、脂肪浸润(P = 0.01)和动脉受累(P = 0.04)更为常见。

结论

该研究证实欧洲扩张型心肌病的发病率高于先前报道,并强调需要提高诊断敏感性,特别是因为目前药物治疗非常有效。

相似文献

1
Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group.扩张型心肌病的流行病学。一项对5252例尸检的前瞻性研究。心肌疾病研究组。
Eur Heart J. 1997 Jan;18(1):117-23. doi: 10.1093/oxfordjournals.eurheartj.a015092.
2
Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy.扩张型心肌病患者接受最佳药物治疗后的长期随访期间心脏性猝死的发生率及预测因素
Ital Heart J. 2001 Mar;2(3):213-21.
3
[Changes in the cardiac vascular bed in dilated and hypertrophic cardiomyopathy].[扩张型和肥厚型心肌病中心血管床的变化]
Kardiologiia. 1989 Nov;29(11):116-20.
4
T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.T1 映射与非缺血性心肌病的转归:全因死亡率和心力衰竭。
JACC Cardiovasc Imaging. 2016 Jan;9(1):40-50. doi: 10.1016/j.jcmg.2015.12.001.
5
Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.过去 30 多年来,托斯卡纳地区特发性扩张型心肌病患者生存率的提高:基于证据的管理的影响。
Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.
6
[Hypertrophic cardiomyopathy with left ventricular dilatation].[伴有左心室扩张的肥厚型心肌病]
J Cardiol. 1988 Jun;18(2):319-28.
7
Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.经冠状动脉内 CD34+ 干细胞移植治疗非缺血性扩张型心肌病患者:5 年随访结果。
Circ Res. 2013 Jan 4;112(1):165-73. doi: 10.1161/CIRCRESAHA.112.276519. Epub 2012 Oct 12.
8
[The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].[扩张型心肌病的自然病史:的里雅斯特心肌疾病登记处综述]
Ital Heart J Suppl. 2004 Apr;5(4):253-66.
9
New-onset left bundle branch block independently predicts long-term mortality in patients with idiopathic dilated cardiomyopathy: data from the Trieste Heart Muscle Disease Registry.新出现的左束支传导阻滞独立预测特发性扩张型心肌病患者的长期死亡率:来自的里雅斯特心肌疾病登记处的数据。
Europace. 2014 Oct;16(10):1450-9. doi: 10.1093/europace/euu016. Epub 2014 Feb 18.
10
[Histopathological analysis of cellular infiltration in 42 autopsied cases of dilated cardiomyopathy].[42例扩张型心肌病尸检病例细胞浸润的组织病理学分析]
J Cardiol. 1993;23(4):343-50.

引用本文的文献

1
Prevalence and Incidence of Dilated Cardiomyopathy in the United States and Western Europe: A Systematic Review.美国和西欧扩张型心肌病的患病率与发病率:一项系统评价
Cardiol Res. 2025 Jul 8;16(4):295-305. doi: 10.14740/cr2071. eCollection 2025 Aug.
2
Revisiting Secondary Dilative Cardiomyopathy.再探继发性扩张型心肌病
Int J Mol Sci. 2025 Apr 28;26(9):4181. doi: 10.3390/ijms26094181.
3
Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics.利用影像组学评估扩张型心肌病:结合多模态心血管成像与遗传学
ESC Heart Fail. 2025 Aug;12(4):2669-2690. doi: 10.1002/ehf2.15307. Epub 2025 Apr 24.
4
Diagnosis and management of dilated cardiomyopathy: a systematic review of clinical practice guidelines and recommendations.扩张型心肌病的诊断与管理:临床实践指南与建议的系统评价
Eur Heart J Qual Care Clin Outcomes. 2025 Mar 3;11(2):206-222. doi: 10.1093/ehjqcco/qcae109.
5
Paediatric HeartMate 3™, the Uneventful 22-Month Journey to Transplantation of a 14-Year-Old-Patient-Time for Prolonged LVAD Support in Children?小儿HeartMate 3™,一名14岁患者移植前22个月的平稳历程——儿童长期左心室辅助装置支持的时机?
J Cardiovasc Dev Dis. 2024 Sep 18;11(9):288. doi: 10.3390/jcdd11090288.
6
The use of D-dimer in the diagnosis and risk assessment of intracardiac thrombus among patients with dilated cardiomyopathy.D-二聚体在扩张型心肌病患者心腔内血栓诊断和风险评估中的应用。
Sci Rep. 2023 Oct 23;13(1):18075. doi: 10.1038/s41598-023-45077-4.
7
Genome-wide association study of dilated cardiomyopathy-induced heart failure associated with renal insufficiency in a Chinese population.在中国人群中,全基因组关联研究扩张型心肌病引起的心力衰竭与肾功能不全的相关性。
BMC Cardiovasc Disord. 2023 Jun 30;23(1):335. doi: 10.1186/s12872-023-03370-0.
8
Structural and signaling proteins in the Z-disk and their role in cardiomyopathies.Z线中的结构蛋白和信号蛋白及其在心肌病中的作用。
Front Physiol. 2023 Mar 2;14:1143858. doi: 10.3389/fphys.2023.1143858. eCollection 2023.
9
A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches.扩张型心肌病(DCM)综述:最新进展,特别强调基于组学的方法
J Cardiovasc Dev Dis. 2022 Jun 1;9(6):174. doi: 10.3390/jcdd9060174.
10
Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controls.成年一级亲属与匹配对照中扩张型心肌病的发病率。
Int J Cardiol Heart Vasc. 2022 May 30;41:101065. doi: 10.1016/j.ijcha.2022.101065. eCollection 2022 Aug.